Kolář Z - Search Results

1

Tumor-Infiltrating Lymphocytes/Plasmocytes in Chemotherapeutically Non-Influenced Triple-Negative Breast Cancers - Correlation with Morphological and Clinico-Pathological Parameters.

Kolečková M, Kolář Z, Ehrmann J, Kořínková G, Zlámalová N, Melichar B, Trojanec R. Kolečková M, et al. Among authors: kolar z. Klin Onkol. 2019 Fall;32(5):380-387. doi: 10.14735/amko2019380. Klin Onkol. 2019. PMID: 31610672 English.

2

Metastatic Clear Cell Renal Carcinoma Without Evidence of a Primary Renal Tumour Mimicking Advanced Stage of Malignant Lung Tumour.

Kolečková M, Tichý T, Melichar B, Veverková L, Hes O, Kolek V, Kolář Z. Kolečková M, et al. Among authors: kolar z. Klin Onkol. 2019 Spring;32(Supplementum1):154-156. Klin Onkol. 2019. PMID: 31064187 English.

3

Epithelial to mesenchymal transition and microRNA expression are associated with spindle and apocrine cell morphology in triple-negative breast cancer.

Koleckova M, Ehrmann J, Bouchal J, Janikova M, Brisudova A, Srovnal J, Staffova K, Svoboda M, Slaby O, Radova L, Vomackova K, Melichar B, Veverkova L, Kolar Z. Koleckova M, et al. Among authors: kolar z. Sci Rep. 2021 Mar 4;11(1):5145. doi: 10.1038/s41598-021-84350-2. Sci Rep. 2021. PMID: 33664322 Free PMC article.

4

MicroRNAs in triple-negative breast cancer.

Koleckova M, Janikova M, Kolar Z. Koleckova M, et al. Among authors: kolar z. Neoplasma. 2018;65(1):1-13. doi: 10.4149/neo_2018_170115N36. Neoplasma. 2018. PMID: 29322783 Review.

5

Age-associated prognostic and predictive biomarkers in patients with breast cancer.

Kolečková M, Kolář Z, Ehrmann J, Kořínková G, Trojanec R. Kolečková M, et al. Among authors: kolar z. Oncol Lett. 2017 Jun;13(6):4201-4207. doi: 10.3892/ol.2017.6000. Epub 2017 Apr 6. Oncol Lett. 2017. PMID: 28599421 Free PMC article.

6

BCL2 is an independent predictor of outcome in basal-like triple-negative breast cancers treated with adjuvant anthracycline-based chemotherapy.

Bouchalova K, Svoboda M, Kharaishvili G, Vrbkova J, Bouchal J, Trojanec R, Koudelakova V, Radova L, Cwiertka K, Hajduch M, Kolar Z. Bouchalova K, et al. Among authors: kolar z. Tumour Biol. 2015 Jun;36(6):4243-52. doi: 10.1007/s13277-015-3061-7. Epub 2015 Jan 24. Tumour Biol. 2015. PMID: 25616695

7

Evaluation of HER2 Gene Status in Breast Cancer Samples with Indeterminate Fluorescence in Situ Hybridization by Quantitative Real-Time PCR.

Koudelakova V, Berkovcova J, Trojanec R, Vrbkova J, Radova L, Ehrmann J, Kolar Z, Melichar B, Hajduch M. Koudelakova V, et al. Among authors: kolar z. J Mol Diagn. 2015 Jul;17(4):446-55. doi: 10.1016/j.jmoldx.2015.03.007. Epub 2015 May 5. J Mol Diagn. 2015. PMID: 25956448 Free article.

8

Immunohistochemical analysis of the functional status of estrogen receptor cascade in breast cancer.

Kolár Z, Ehrmann J Jr, Dusková M. Kolár Z, et al. Neoplasma. 1998;45(2):83-7. Neoplasma. 1998. PMID: 9687888

9

Tpl-2/Cot and COX-2 in breast cancer.

Krcova Z, Ehrmann J, Krejci V, Eliopoulos A, Kolar Z. Krcova Z, et al. Among authors: kolar z. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008 Jun;152(1):21-5. doi: 10.5507/bp.2008.003. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008. PMID: 18795070 Review.

10

[Can Analysis of Cellular Lipidome Contribute to Discrimination of Tumour and Non-tumour Colon Cells?].

Hofmanová J, Slávik J, Tylichová Z, Ovesná P, Bouchal J, Kolář Z, Ehrmann J, Levková M, Machala M, Vondráček J, Kozubík A. Hofmanová J, et al. Among authors: kolar z. Klin Onkol. 2018 Spring;31(Supplementum1):151-154. Klin Onkol. 2018. PMID: 29808691 Czech.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

220 results

Search Page